Nirvana Life Sciences Statistics
Total Valuation
CSE:NIRV has a market cap or net worth of CAD 3.20 million. The enterprise value is 3.29 million.
| Market Cap | 3.20M | 
| Enterprise Value | 3.29M | 
Important Dates
The next estimated earnings date is Tuesday, December 9, 2025.
| Earnings Date | Dec 9, 2025 | 
| Ex-Dividend Date | n/a | 
Share Statistics
CSE:NIRV has 22.82 million shares outstanding. The number of shares has increased by 93.19% in one year.
| Current Share Class | 22.82M | 
| Shares Outstanding | 22.82M | 
| Shares Change (YoY) | +93.19% | 
| Shares Change (QoQ) | +373.19% | 
| Owned by Insiders (%) | 11.96% | 
| Owned by Institutions (%) | n/a | 
| Float | 18.32M | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| PB Ratio | -6.05 | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | -9.51 | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 | 
| Quick Ratio | 0.03 | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | n/a | 
Financial Efficiency
| Return on Equity (ROE) | n/a | 
| Return on Assets (ROA) | -1,048.11% | 
| Return on Invested Capital (ROIC) | n/a | 
| Return on Capital Employed (ROCE) | 63.67% | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | n/a | 
| Employee Count | 2 | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
| Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
The stock price has decreased by -81.33% in the last 52 weeks. The beta is 0.22, so CSE:NIRV's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 | 
| 52-Week Price Change | -81.33% | 
| 50-Day Moving Average | 0.08 | 
| 200-Day Moving Average | 0.14 | 
| Relative Strength Index (RSI) | 83.63 | 
| Average Volume (20 Days) | 50 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | n/a | 
Income Statement
| Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | -336,032 | 
| Pretax Income | -346,425 | 
| Net Income | -346,296 | 
| EBITDA | n/a | 
| EBIT | -336,032 | 
| Earnings Per Share (EPS) | -0.04 | 
Balance Sheet
The company has 1,744 in cash and 104,789 in debt, giving a net cash position of -103,045 or -0.00 per share.
| Cash & Cash Equivalents | 1,744 | 
| Total Debt | 104,789 | 
| Net Cash | -103,045 | 
| Net Cash Per Share | -0.00 | 
| Equity (Book Value) | -527,733 | 
| Book Value Per Share | -0.02 | 
| Working Capital | -527,732 | 
Cash Flow
| Operating Cash Flow | -1.02M | 
| Capital Expenditures | n/a | 
| Free Cash Flow | n/a | 
| FCF Per Share | n/a | 
Margins
| Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
CSE:NIRV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -93.19% | 
| Shareholder Yield | -93.19% | 
| Earnings Yield | -10.84% | 
| FCF Yield | n/a | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
The last stock split was on March 24, 2025. It was a reverse split with a ratio of 0.1.
| Last Split Date | Mar 24, 2025 | 
| Split Type | Reverse | 
| Split Ratio | 0.1 | 
Scores
| Altman Z-Score | n/a | 
| Piotroski F-Score | 1 |